glp-1/gip/glucagon triple agonist retatrutide mechanism glp-1 gip glucagon GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation Retatrutide: The triple agonist powering
Description
However, for the best results, its also essential to eat healthily, stay active, and seek support if you're feeling stressed or down
M., & Links, T
[2] That triple action is the whole design bet
The lifestyle interventions should be monitored, adapted, and perpetuated in an informed consent with the patient over the years, regardless of whether additional medical or surgical therapy is started in the course of T2D or obesity (16, 17, 2325)
Since GLP-1 drugs slow gastric emptying, they shouldnt be used in people with gastroparesis
Boland et al
